Endolymphatic hydrops induced by chronic administration of vasopressin.
Naftalin
L
L
D000818:Animals; D051399:Aquaporin 2; D051403:Aquaporin 6; D020346:Aquaporins / Q000502:physiology; D018159:Endolymphatic Hydrops / Q000139:chemically induced* / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D008575:Meniere Disease / Q000209:etiology / Q000503:physiopathology; D017483:Receptors, Vasopressin / Q000502:physiology; D014667:Vasopressins / Q000008:administration & dosage / Q000502:physiology / Q000633:toxicity*
C496023:AQP2 protein, human; D051399:Aquaporin 2; D051403:Aquaporin 6; D020346:Aquaporins; D017483:Receptors, Vasopressin; D014667:Vasopressins